Clinical trial
Aldara for the Treatment of Extensive Alopecia Areata
NCT00177021 · Hordinsky, Maria K., MD, Other · Completed
Key facts
| NCT number | NCT00177021 |
|---|---|
| Title | Aldara for the Treatment of Extensive Alopecia Areata |
| Official title | Aldara for the Treatment of Extensive Alopecia Areata |
| Lead sponsor | Hordinsky, Maria K., MD, Other |
| Collaborators | National Alopecia Areata Foundation 3M Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Alopecia Areata |
| Intervention type | Drug |
| Interventions | Aldara Cream 5% |
| Enrollment | 20 |
| Start date | Oct 1, 2000 |
| Completion | Aug 1, 2002 |
| First posted | Sep 15, 2005 |
| Last update posted | Nov 13, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: